AR106367A1 - Composiciones de polisacáridos entrecruzables in situ y usos de las mismas - Google Patents

Composiciones de polisacáridos entrecruzables in situ y usos de las mismas

Info

Publication number
AR106367A1
AR106367A1 ARP160103104A ARP160103104A AR106367A1 AR 106367 A1 AR106367 A1 AR 106367A1 AR P160103104 A ARP160103104 A AR P160103104A AR P160103104 A ARP160103104 A AR P160103104A AR 106367 A1 AR106367 A1 AR 106367A1
Authority
AR
Argentina
Prior art keywords
situ
compositions
polisacárides
intributable
same
Prior art date
Application number
ARP160103104A
Other languages
English (en)
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of AR106367A1 publication Critical patent/AR106367A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/594—Mixtures of polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87—Application Devices; Containers; Packaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/882—Mixing prior to application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/95—Involves in-situ formation or cross-linking of polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Composiciones estériles de polisacáridos entrecruzables in situ para acrecentar, rellenar o reemplazar tejidos blandos en diversas aplicaciones cosméticas y terapéuticas. La composición comprende un primer polisacárido derivado funcionalizado con un grupo nucleófilo y un segundo polisacárido derivado funcionalizado con un grupo electrófilo. Dichos grupos funcionales nucleófilos y electrófilos forman enlaces covalentes in situ después de la coinyección en el cuerpo de un paciente, para dar lugar a la formación de un hidrogel entrecruzado en el sitio de la coinyección.
ARP160103104A 2015-10-16 2016-10-11 Composiciones de polisacáridos entrecruzables in situ y usos de las mismas AR106367A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15002953.6A EP3156044A1 (en) 2015-10-16 2015-10-16 In situ cross-linkable polysaccharide compositions and uses thereof

Publications (1)

Publication Number Publication Date
AR106367A1 true AR106367A1 (es) 2018-01-10

Family

ID=54540785

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160103104A AR106367A1 (es) 2015-10-16 2016-10-11 Composiciones de polisacáridos entrecruzables in situ y usos de las mismas

Country Status (17)

Country Link
US (1) US11000467B2 (es)
EP (2) EP3156044A1 (es)
JP (2) JP7368940B2 (es)
KR (1) KR102694278B1 (es)
CN (1) CN108348454A (es)
AR (1) AR106367A1 (es)
AU (1) AU2016338072B2 (es)
BR (1) BR112018007683A2 (es)
CA (1) CA3000588C (es)
ES (1) ES2969063T3 (es)
HK (1) HK1254733A1 (es)
IL (1) IL258205B (es)
MX (1) MX2018004235A (es)
RU (1) RU2734419C2 (es)
TW (1) TWI789338B (es)
WO (1) WO2017063749A1 (es)
ZA (1) ZA201801761B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3638345A1 (en) 2017-06-13 2020-04-22 Merz Pharma GmbH & Co. KGaA Mixing nozzle, application device, kit and method using the mixing nozzle or application device
WO2019002371A1 (en) * 2017-06-28 2019-01-03 Nestlé Skin Health Sa GLYCOSAMINOGLYCAN GEL WITH BIS-TRIS BUFFER
CN110636870A (zh) * 2017-10-10 2019-12-31 依娜完美护肤解决方案有限公司 制备包含透明质酸和羟基磷灰石的真皮填充物组合物的方法以及包含透明质酸和羟基磷灰石的真皮填充物组合物
JP7550059B2 (ja) * 2018-06-28 2024-09-12 ハルーラ リミテッド 架橋ポリカルボキシル化多糖およびその使用方法
AU2019407867B2 (en) * 2018-12-19 2024-09-26 Merz Pharma Gmbh & Co. Kgaa Aldehyde-modified hyaluronic acid, method for preparing same and applications thereof
BR112021012042A2 (pt) * 2018-12-20 2021-09-21 Lg Chem, Ltd. Preenchedor com excelentes propriedades de preenchedor compreendendo hidrogel de ácido hialurônico
CN109880125B (zh) * 2019-02-21 2021-07-13 武汉纺织大学 一种皮下填充透明质酸凝胶的制备方法
CN112538171A (zh) * 2019-09-20 2021-03-23 天津大学 一种可注射可降解肝素水凝胶及其制备方法和应用
CN111249532A (zh) * 2020-01-16 2020-06-09 广东省人民医院(广东省医学科学院) 一种用于软骨修复的可注射透明质酸水凝胶及其制备方法
EP4100072A1 (en) * 2020-02-04 2022-12-14 Boston Scientific Scimed Inc. Injectable in vivo crosslinking materials for use as soft tissue fillers
CN111253629B (zh) * 2020-03-17 2021-06-15 江苏地韵医疗科技有限公司 一种凝胶、其成套原料及应用
CN113929792B (zh) * 2020-07-13 2023-03-10 孛朗孚(杭州)生物科技有限公司 一种醛基化修饰的透明质酸(钠)及其合成方法和应用
CN112280105A (zh) * 2020-11-11 2021-01-29 河北大学 一种纤维素基自修复水凝胶及其制备方法与应用
CN112472819B (zh) * 2020-11-30 2022-04-22 西安交通大学 一种共载阿霉素和吲哚菁绿的多糖基纳米粒子及其制备方法和应用
CN113024845A (zh) * 2021-03-17 2021-06-25 广西医科大学 一种醛肼交联型抗菌水凝胶敷料的制备方法
CN113827779B (zh) * 2021-08-14 2022-07-26 中国海洋大学 一种生物多糖水凝胶及其制备方法和应用
WO2023191553A1 (ko) * 2022-04-01 2023-10-05 한양대학교 산학협력단 신축성 자가치유 하이드로젤
CN115463262B (zh) * 2022-08-11 2024-06-04 南方医科大学第五附属医院 一种水凝胶复合修复补片及其制备方法与应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616568A (en) 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
US6630457B1 (en) 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
CA2392419A1 (en) 1999-11-26 2001-06-07 The Regents Of The University Of Michigan Reversible cross-linked hydrogels
US7465766B2 (en) 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
EP3456749B1 (en) 2008-02-29 2021-07-14 PVAC Medical Technologies Ltd. A substituted polyvinyl alcohol reagent
ITRM20080636A1 (it) * 2008-11-28 2010-05-29 Univ Palermo Procedimento per la produzione di derivati funzionalizzati dell acido ialuronico e relativi idrogeli.
US8186843B2 (en) 2008-12-17 2012-05-29 M-Edge Accessories, Llc Booklight for a protective cover of an eReader
CZ302503B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
US8197849B2 (en) 2010-02-12 2012-06-12 National Health Research Institutes Cross-linked oxidated hyaluronic acid for use as a vitreous substitute
US20140178512A1 (en) * 2011-02-22 2014-06-26 Merz Pharma Gmbh & Co. Kgaa In situ formation of a filler
EP2716662A4 (en) * 2011-05-31 2014-11-19 Univ Tokyo HYDROGEL AND METHOD FOR ITS MANUFACTURE
US20140105960A1 (en) * 2012-10-12 2014-04-17 Children's Medical Center Corporation Hydrogels for tissue regeneration
CN105209075B (zh) * 2013-04-18 2019-12-13 香港科技大学 生物相容性原位水凝胶
BR112017013170A2 (pt) 2014-12-18 2018-01-02 Galderma Sa enxerto de ciclodextrina por ligações amida a um éter ácido hialurônico reticulado e usos do mesmo
CN104940944A (zh) * 2015-06-04 2015-09-30 浙江大学 蛋白聚糖酶抑制剂结合体外交联透明质酸水凝胶的制作方法及在治疗骨关节炎药物中的应用

Also Published As

Publication number Publication date
CA3000588A1 (en) 2017-04-20
IL258205A (en) 2018-05-31
WO2017063749A1 (en) 2017-04-20
RU2018109536A (ru) 2019-11-18
US11000467B2 (en) 2021-05-11
RU2018109536A3 (es) 2020-01-17
JP2022136103A (ja) 2022-09-15
EP3156044A1 (en) 2017-04-19
HK1254733A1 (zh) 2019-07-26
US20180318203A1 (en) 2018-11-08
AU2016338072B2 (en) 2021-12-02
EP3324931A1 (en) 2018-05-30
BR112018007683A2 (pt) 2018-11-06
JP2018530547A (ja) 2018-10-18
RU2734419C2 (ru) 2020-10-16
ES2969063T3 (es) 2024-05-16
TWI789338B (zh) 2023-01-11
IL258205B (en) 2021-02-28
KR20180064390A (ko) 2018-06-14
TW201718035A (zh) 2017-06-01
JP7368940B2 (ja) 2023-10-25
CA3000588C (en) 2023-08-01
EP3324931B1 (en) 2023-11-29
ZA201801761B (en) 2021-09-29
KR102694278B1 (ko) 2024-08-09
CN108348454A (zh) 2018-07-31
AU2016338072A1 (en) 2018-05-10
MX2018004235A (es) 2018-08-01

Similar Documents

Publication Publication Date Title
AR106367A1 (es) Composiciones de polisacáridos entrecruzables in situ y usos de las mismas
BR112018012182A2 (pt) dispositivo para tratamento fotodinâmico
ECSP19010079A (es) 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2
CL2019003636A1 (es) Polinucleótidos de aadc para el tratamiento de la enfermedad de parkinson.
EP3525885A4 (en) ARTIFICIAL TEARS, CONTACT LENSES AND VEHICLE COMPOSITIONS FOR MEDICINAL PRODUCTS AND THEIR USE METHODS
BR112018074450A2 (pt) composições e métodos para a utilização de nintedanib para melhorar o sucesso da cirurgia do glaucoma
BR112015021888A8 (pt) inibidores de dna-pk, seus usos e composição farmacêutica
CL2017002767A1 (es) Nuevas proteínas específicas para cd137.
EA201891186A1 (ru) Антитела, нейтрализующие вирус иммунодефицита человека
BR112015020389A8 (pt) compostos carbazol úteis como inibidores de bromodomínio, seu uso, bem como composição e produto farmacêuticos compreendendo os mesmos
AR107967A1 (es) Ácido hialurónico modificado, método para su preparación y usos del mismo
NI201500067A (es) Compuestos de pirrolopirimidina como inhibidores de quinasa
BR112017008344A2 (pt) extrato, uso de um extrato, e, composição cosmética ou dermofarmacêutica.
BR112017016759A2 (pt) recipiente de plástico pré-carregado, kit, uso do recipiente de plástico pré-carregado, método para o tratamento de uma doença ou condição, método para o tratamento cosmético da pele
AU2015287920A8 (en) Micronized Wharton's Jelly
CY1123366T1 (el) Παραγωγα 8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δeκανιου
BR112017007748A2 (pt) “composição farmacêutica, agente antialérgico, composição alimentar, composição cosmética, uso de um extrato, e, método para prevenir ou tratar uma doença alérgica
BR112016010072A8 (pt) conjugado, composição farmacêutica, usos do conjugado ou da composição farmacêutica, e de polissacarídeo de vi fragmentado, e, método para a fabricação de um conjugado
PE20151603A1 (es) Anticuerpos anti-lamp1 y conjugados anticuerpo farmaco, y usos de estos
CL2021000129A1 (es) Apirasas solubilizadas, métodos y usos
BR112016029996A2 (pt) utilização cosmética, composição e método cosmético para tratar os odores corporais
BR112017027897A2 (pt) usos terapêuticos das formulações de berberina
EA201792085A1 (ru) Смешанные дисульфидные конъюгаты тиенопиридиновых соединений и их применение
EA201500830A1 (ru) Противогрибковая композиция для наружного применения для лечения онихомикоза
WO2015063613A3 (en) Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents